Telehealth and wellness platform Visit Health has raised Rs 250 crore ($30 million) in a combination of primary and secondary purchase of stake in the company held by Docprime Technologies, the current promoters and employees.
Company stated in a press release that they will use the funds to expand its business which involves a strategic partnership with health and wellness platform TatvaCare.
In October 2021, DocPrime invested around $7.5 million in Visit Health. The New Delhi-based company had also scooped up $1.4 million in seed round from investors such as MapmyIndia, Snapdeal co-founders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna.
In May, PB Fintech said that it will divest 29% of its holdings in Visit , which will be valued at Rs 76 crore ($9 million). The firm also added that it will make a divestment of Rs 2 crore in Visit Internet.
Eight-year-old Visit Health offers customized wellness & OPD programs for SMEs and corporates’ employees and their families. It claims to serve more than 400 companies through its network of hospitals.
Firm registered nearly three-fold jump in its revenue to Rs 53 crore from Rs 17.55 crore in FY22. The company managed to keep its losses below Rs 1 crore in FY23. It is yet to file FY24 numbers.